• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-4652-5p 通过靶向 RND1 调节细胞黏附并促进肺鳞癌进展。

MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.

机构信息

Department of Cardiac Thoracic Surgery, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), No.61, Jiefang West Road, Furong District, Changsha, 410000, China.

出版信息

Appl Biochem Biotechnol. 2022 Jul;194(7):3031-3043. doi: 10.1007/s12010-022-03897-6. Epub 2022 Mar 25.

DOI:10.1007/s12010-022-03897-6
PMID:35334070
Abstract

Lung squamous cell carcinoma (LUSC) is one subtype of non-small-cell lung cancer, whose pathogenesis has not been fully understood. Exploring molecular mechanisms of LUSC helps a lot with the development of LUSC novel therapy. Hence, our study aims to investigate novel molecular mechanisms. Differentially expressed miRNAs and mRNAs were acquired from The Cancer Genome Atlas database. A series of assays were applied to test cell functions, including qRT-PCR to analyze RND1 and miR-4652-5p expression, dual-luciferase reporter gene assay to verify the targeting relationship between these two genes, cell counting kit-8 and colony formation assays to evaluate the ability of LUSC cells to proliferate, transwell to examine the migratory and invasive abilities, and western blot to test expression of RND1 and cell adhesion-related proteins. RND1 was lowly expressed while miR-4652-5p was highly expressed in LUSC cells. The correlation between these two genes was significantly negative and miR-4652-5p could downregulate RND1 expression. Additionally, cellular function assays validated that RND1 suppressed LUSC cells to proliferate, migrate, and invade. Besides, this gene might also affect cell adhesion. Furthermore, rescue assay suggested that miR-4652-5p downregulated RND1 expression to promote the progression of LUSC cells. Together, miR-4652-5p targeted RND1 to modulate cell adhesion and the progression of LUSC cells.

摘要

肺鳞状细胞癌(LUSC)是一种非小细胞肺癌,其发病机制尚未完全阐明。探索 LUSC 的分子机制有助于开发 LUSC 的新型治疗方法。因此,我们的研究旨在探讨新的分子机制。从癌症基因组图谱数据库中获得差异表达的 miRNAs 和 mRNAs。应用一系列实验来测试细胞功能,包括 qRT-PCR 分析 RND1 和 miR-4652-5p 的表达、双荧光素酶报告基因实验验证这两个基因的靶向关系、细胞计数试剂盒-8 和集落形成实验评估 LUSC 细胞的增殖能力、Transwell 检测细胞的迁移和侵袭能力,以及 Western blot 检测 RND1 和细胞黏附相关蛋白的表达。在 LUSC 细胞中,RND1 表达水平较低,而 miR-4652-5p 表达水平较高。这两个基因之间的相关性呈显著负相关,miR-4652-5p 可以下调 RND1 的表达。此外,细胞功能实验验证了 RND1 抑制 LUSC 细胞的增殖、迁移和侵袭。此外,该基因可能还会影响细胞黏附。此外,挽救实验表明,miR-4652-5p 通过下调 RND1 表达来促进 LUSC 细胞的进展。总之,miR-4652-5p 通过靶向 RND1 来调节 LUSC 细胞的黏附和进展。

相似文献

1
MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.miR-4652-5p 通过靶向 RND1 调节细胞黏附并促进肺鳞癌进展。
Appl Biochem Biotechnol. 2022 Jul;194(7):3031-3043. doi: 10.1007/s12010-022-03897-6. Epub 2022 Mar 25.
2
miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.miR-223-5p 通过抑制 OTX1 来介导肺鳞癌细胞的恶性进展。
Comput Math Methods Med. 2021 Jul 8;2021:6248793. doi: 10.1155/2021/6248793. eCollection 2021.
3
MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.miR-30a-5p 通过靶向 FBXO45 抑制肺鳞癌细胞增殖。
Histol Histopathol. 2022 May;37(5):483-492. doi: 10.14670/HH-18-424. Epub 2022 Jan 31.
4
H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.H3K27ac 激活的 LINC00519 通过靶向 miR-450b-5p/miR-515-5p/YAP1 轴促进肺鳞癌进展。
Cell Prolif. 2020 May;53(5):e12797. doi: 10.1111/cpr.12797. Epub 2020 Apr 16.
5
LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.LINC01232 通过调控 miR-181a-5p/SMAD2 轴促进肺鳞癌进展。
Am J Med Sci. 2023 Apr;365(4):386-395. doi: 10.1016/j.amjms.2022.12.014. Epub 2022 Dec 18.
6
Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression.长链非编码 RNA LINC00943 在肺鳞癌中的表达及其与肿瘤进展的关系。
J Cardiothorac Surg. 2024 Apr 16;19(1):222. doi: 10.1186/s13019-024-02771-2.
7
DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.DLX6-AS1 通过调控 miR-181a-5p/miR-382-5p/CELF1 轴激活促进肺鳞癌细胞对顺铂的获得性耐药。
Sci Rep. 2021 Oct 25;11(1):21014. doi: 10.1038/s41598-021-99555-8.
8
LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.长链非编码 RNA MIR9-3HG 通过海绵吸附 miR-138-5p 和招募 TAF15 来提高 LIMK1 mRNA 和蛋白水平,从而促进肺鳞癌的发生。
Pathol Res Pract. 2022 Sep;237:153941. doi: 10.1016/j.prp.2022.153941. Epub 2022 May 13.
9
miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1.miR-30a-5p 通过靶向 FOXD1 抑制肺鳞癌细胞的增殖和迁移。
Biomed Res Int. 2020 Apr 13;2020:2547902. doi: 10.1155/2020/2547902. eCollection 2020.
10
MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.miR-210-3p 通过靶向 CELF2 促进肺鳞癌的进展PI3K/AKT 通路。
Med Oncol. 2022 Aug 16;39(11):161. doi: 10.1007/s12032-022-01752-6.

引用本文的文献

1
MiR-1976 affects lung squamous cell carcinoma development by targeting NCAPH.微小RNA-1976通过靶向核仁分裂相关蛋白(NCAPH)影响肺鳞状细胞癌的发展。
J Appl Genet. 2025 Jul 23. doi: 10.1007/s13353-025-00990-4.
2
Novel miRNA markers and their mechanism of esophageal squamous cell carcinoma (ESCC) based on TCGA.基于 TCGA 的新型 miRNA 标志物及其在食管鳞状细胞癌(ESCC)中的作用机制。
Sci Rep. 2024 Nov 8;14(1):27261. doi: 10.1038/s41598-024-76321-0.
3
FOXA2 Activates RND1 to Regulate Arachidonic Acid Metabolism Pathway and Suppress Cisplatin Resistance in Lung Squamous Cell Carcinoma.

本文引用的文献

1
The effect and mechanism of miR-607/CANT1 axis in lung squamous carcinoma.miR-607/CANT1 轴在肺鳞癌中的作用及机制。
Anticancer Drugs. 2021 Aug 1;32(7):693-702. doi: 10.1097/CAD.0000000000001045.
2
miR-1301-3p promotes the proliferation and migration of lung cancer cells via direct repression of polymerase I and transcript release factor.微小RNA-1301-3p通过直接抑制聚合酶I和转录释放因子促进肺癌细胞的增殖和迁移。
Oncol Lett. 2020 Dec;20(6):286. doi: 10.3892/ol.2020.12149. Epub 2020 Sep 23.
3
Long non-coding RNA LINC01116 regulated miR-744-5p/SCN1B axis to exacerbate lung squamous cell carcinoma.
FOXA2 通过激活 RND1 调控花生四烯酸代谢通路抑制肺鳞癌细胞顺铂耐药
Clin Respir J. 2024 Aug;18(8):e13814. doi: 10.1111/crj.13814.
长链非编码 RNA LINC01116 通过调控 miR-744-5p/SCN1B 轴促进肺鳞癌进展。
Cancer Biomark. 2020;28(4):473-482. doi: 10.3233/CBM-190945.
4
miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1.miR-30a-5p 通过靶向 FOXD1 抑制肺鳞癌细胞的增殖和迁移。
Biomed Res Int. 2020 Apr 13;2020:2547902. doi: 10.1155/2020/2547902. eCollection 2020.
5
Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival.泛癌症分析揭示了调控肿瘤发生和患者生存的 miRNA 双链的协同作用。
Nat Commun. 2020 Feb 20;11(1):968. doi: 10.1038/s41467-020-14713-2.
6
Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.头颈部鳞状细胞癌的两种miRNA预后特征:基于TCGA数据集的生物信息学分析
Cancer Med. 2020 Apr;9(8):2631-2642. doi: 10.1002/cam4.2915. Epub 2020 Feb 17.
7
Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.T 滤泡辅助细胞的免疫特征可预测肺鳞状细胞癌的临床预后和治疗影响。
Int Immunopharmacol. 2020 Apr;81:105932. doi: 10.1016/j.intimp.2019.105932. Epub 2019 Dec 10.
8
Identification of seven-gene signature for prediction of lung squamous cell carcinoma.用于预测肺鳞状细胞癌的七基因特征识别。
Onco Targets Ther. 2019 Jul 24;12:5979-5988. doi: 10.2147/OTT.S198998. eCollection 2019.
9
circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1.环状 RNA(circRNA)TP63 通过上调 FOXM1 作为 ceRNA 促进肺鳞癌进展。
Nat Commun. 2019 Jul 19;10(1):3200. doi: 10.1038/s41467-019-11162-4.
10
RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.RND1根据人胶质母细胞瘤干细胞样细胞的解剖定位调节其迁移,并在胶质母细胞瘤中定义了一种预后特征。
Oncotarget. 2018 Sep 18;9(73):33788-33803. doi: 10.18632/oncotarget.26082.